Pfizer Schemed To Block Celebrex Generics, New Suit Says
Pfizer Inc. allegedly ripped off consumers by fraudulently getting its patent for blockbuster arthritis drug Celebrex reissued so as to bring "sham litigation" and keep generic versions of the drug off...To view the full article, register now.
Already a subscriber? Click here to view full article